# Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer

> **NCT00330044** · PHASE1 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 18 (actual)

## Conditions studied

- Inoperable Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Premetrexed (Alimta)
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT00330044
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2009-08
- **Final completion:** 2009-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00330044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00330044, "Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00330044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*